US$ 23.13
glp-1 therapies success rates Many adults stop therapy within a year with low restart rates, analysis finds GLP-1 therapies and mortality risk:
Description
Remember that all medications carry some risks, but for most people, the benefits of GLP-1 treatment significantly outweigh the potential downsides

doi: 10.1016/j.ad.2023.06.017

Semin Ophthalmol
JAMA - J Am Med Assoc 316(5):500508

Across the studies that were included, over 32,000 subjects received GLP-1 agonists and over 27,000 received placebo

3 Liraglutide (Saxenda )
